Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Linden Advisors
Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Linden Advisors
from 13F filings
Historical chart of Linden Advisors investment in Halozyme Therapeutics Inc Note 1.000 8/1
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by Linden Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by Linden Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $18M | 13M | 1.41 |
| 2025-03-31 | $4.8M | 3.8M | 1.28 |
| 2024-12-31 | $4.1M | 3.8M | 1.08 |
| 2023-09-30 | $77B | 82M | 937.06 |
Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1
View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1